0
Research Letters |

Varicella-Zoster Virus Expression in the Cerebral Arteries of Diabetic Subjects FREE

Maria A. Nagel, MD; Igor Traktinskiy, BS; Alexander Choe, BA; April Rempel; Don Gilden, MD
[+] Author Affiliations

Author Affiliations: Departments of Neurology (Drs Nagel and Gilden, Messrs Traktinskiy and Choe, and Ms Rempel) and Microbiology (Dr Gilden), University of Colorado School of Medicine, Aurora.


Arch Neurol. 2012;69(1):142-144. doi:10.1001/archneur.69.1.142.
Text Size: A A A
Published online

Primary varicella-zoster virus (VZV) infection causes varicella (chickenpox), after which VZV becomes latent in ganglionic neurons along the entire neuraxis. A decline in cell-mediated immunity to VZV in elderly and immunocompromised individuals results in zoster (shingles). Within the first year after herpes zoster, there is a 30% increased risk of stroke.1,2 Approximately one-third of patients with VZV vasculopathy do not have zoster rash and diabetic patients are at greater risk for both zoster3 and stroke; therefore, we examined the cerebral arteries of 4 diabetic subjects for the presence of VZV DNA and antigen.

Cerebral arteries obtained from 4 subjects with diabetes less than 24 hours after they died were analyzed. All subjects had diabetes and no history of zoster infection, transient ischemic attacks, stroke, or immunosuppression. Subject 1 was a 51-year-old woman with hypertension who died of drug overdose; subject 2 was a 60-year-old man with systemic lupus erythematosus who died of asphyxia; subject 3 was a 51-year-old woman who died of myocardial infarction; and subject 4 was a 60-year-old woman with melanoma, hypertension, and hyperlipidemia who died of a drug overdose. An average of 17 pieces of cerebral arteries (about 10 mm/piece) from each subject were analyzed (total of 68). Each piece was cut in half. DNA was extracted from the first half and analyzed by real-time polymerase chain reaction for the presence of VZV DNA using VZV gene 63 specific primers (gene 63-forward 5′-GCTTACGCGCTACTTTAATGGAA-3′ and gene 63-reverse 5′-GCCTCAATGAACCCGTCTTC-3′) and probes (gene 63 5′-TGTCCCATCGACCCCCTCGG-3′).4 Positive controls were provided by amplification of serial dilutions of known quantities of VZV DNA. Negative controls were provided by omission of VZV DNA from the polymerase chain reaction, which was performed 3 times. The other half was formalin-fixed and paraffin-embedded. If VZV DNA was detected, immunohistochemical analysis was performed on the remaining formalin-fixed, paraffin-embedded arterial sections for VZV gene 63 protein and leukocyte CD45 antigen. Limited arterial tissue precluded a search for additional antigens. Slides were viewed by Nikon Eclipse E800 microscopy with AxioVision digital imaging software (Carl Zeiss MicroImaging GmbH).

Multiple cerebral arteries from 4 diabetic subjects were analyzed for the presence of VZV DNA. Because 1 of 17 arterial pieces from subject 3 was found to contain 3740 copies of VZV DNA per microgram of total DNA, multiple 6-μm sections were prepared from the corresponding formalin-fixed, paraffin-embedded piece for histological and immunohistochemical analysis.

The 1 piece was then analyzed histologically by hematoxylin-eosin staining and for VZV gene 63 protein and CD45 antigen expression. Hematoxylin-eosin staining revealed inflammation in the arterial adventitia (Figure 1A, D, and G), mostly in region 1. Cells containing VZV antigen were seen in noncontiguous regions 1 and 3 separated by 300 μm (Figure 1B and H); the intervening region 2 did not contain VZV antigen (Figure 1E). Staining with control normal rabbit serum was negative in all 3 regions (Figure 1C, F, and I). Leukocytes in region 1 that expressed CD45 antigen (Figure 2B) were associated with cells containing VZV antigen (Figure 2A). Varicella-zoster virus antigen and cells expressing CD45 antigen were also found in region 3 but not in region 2 (Figure 2C and D).

Place holder to copy figure label and caption
Graphic Jump Location

Figure 1. Histological examination of the varicella-zoster virus (VZV)–positive cerebral artery from neurologically asymptomatic diabetic subject 3. A, A hematoxylin-eosin–stained section of region 1 of VZV DNA–positive artery showed inflammation restricted to the arterial adventitia (arrow). B, Incubation of the adjacent section with rabbit anti-VZV gene 63 antibodies6 revealed VZV antigen in the adventitia of 5 consecutive arterial sections spanning 30 μm (arrows) that was not seen with control normal rabbit serum (C). D, A hematoxylin-eosin–stained section of region 2 approximately 150 μm downstream from region 1 of the VZV DNA–positive artery revealed minimal inflammation and no staining with rabbit anti-VZV IgG antibody (E) or control normal rabbit serum (F). G, A hematoxylin-eosin–stained section of region 3 approximately 150 μm downstream from region 2 again showed inflammation in the adventitia. Region 3 was positive for VZV antigen staining in all 10 sections spanning 60 μm (arrow) but not with control normal rabbit serum (I), indicating that VZV infection in the artery was not contiguous (original magnification ×200).

Place holder to copy figure label and caption
Graphic Jump Location

Figure 2. Detection of cells containing varicella-zoster virus and cells expressing CD45 antigen in noncontiguous regions of the arterial adventitia. Arterial regions 1 and 2 after incubation with a 1:400 dilution of mouse monoclonal anti-CD45 antibody (Dako). Region 1 contained varicella-zoster virus antigen (A, arrow) as well as cells expressing CD45 antigen (B, arrow). Region 2 did not contain varicella-zoster virus antigen (C) or cells expressing CD45 antigen (D). Region 3 was positive for varicella-zoster virus antigen and also contained CD45-positive cells (not shown) (original magnification ×600).

Varicella-zoster virus infection of a cerebral artery in the absence of neurologic symptoms related to that artery was first found in the temporal artery of a patient with VZV vasculopathy.5 Extension of asymptomatic VZV infection of a cerebral artery in a diabetic subject raises several issues. First, because strokes are common in people with diabetes and attributed to atherosclerosis, it may be prudent to consider VZV vasculopathy as an additional cause of stroke in people with diabetes, particularly since VZV vasculopathy is treatable with antiviral drugs. Second, VZV antigen was found in noncontiguous arterial regions, underlining the need to examine multiple areas of a single artery to identify virus, just as multiple areas are examined to diagnose giant cell arteritis. Third, the detection of VZV exclusively in arterial adventitia supports earlier observations that VZV vasculopathy begins in the adventitia, most likely after transaxonal spread of virus from ganglionic afferent fibers.5,6 Finally, while more diabetic subjects require study, identification of cells expressing CD45 in proximity to cells containing VZV antigen points to the need for further analysis of the immune repertoire in cerebrovascular remodeling and stroke.

Correspondence: Dr Nagel, Department of Neurology, University of Colorado School of Medicine, PO Box B182, 12700 E 19th Ave, Aurora, CO 80045 (maria.nagel@ucdenver.edu).

Author Contributions:Study concept and design: Nagel and Gilden. Acquisition of data: Nagel, Traktinskiy, Choe, Rempel, and Gilden. Analysis and interpretation of data: Nagel and Gilden. Drafting of the manuscript: Nagel and Gilden. Critical revision of the manuscript for important intellectual content: Nagel, Traktinskiy, Choe, and Rempel. Obtained funding: Nagel and Gilden. Administrative, technical, and material support: Nagel, Traktinskiy, Choe, and Rempel. Study supervision: Nagel and Gilden.

Financial Disclosure: None reported.

Funding/Support: This study was supported by National Institutes of Health grants NS067070 (Dr Nagel), AG032958, and AG006127 (Dr Gilden). Ms Rempel's work was supported by National Institutes of Health grant 5R25GM083333.

Additional Contributions: We thank Marina Hoffman, BA, for editorial assistance and Cathy Allen for manuscript preparation.

Kang JH, Ho JD, Chen YH, Lin HC. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study.  Stroke. 2009;40(11):3443-3448
PubMed   |  Link to Article
Lin HC, Chien CW, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study.  Neurology. 2010;74(10):792-797
PubMed   |  Link to Article
Heymann AD, Chodick G, Karpati T,  et al.  Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel.  Infection. 2008;36(3):226-230
PubMed   |  Link to Article
Cohrs RJ, Gilden DH. Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia.  J Virol. 2007;81(6):2950-2956
PubMed   |  Link to Article
Salazar R, Russman AN, Nagel MA,  et al.  Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement.  Arch Neurol. 2011;68:517-520
PubMed   |  Link to Article
Nagel MA, Traktinskiy I, Azarkh Y,  et al.  Varicella zoster virus vasculopathy: analysis of virus-infected arteries.  Neurology. 2011;77(4):364-370
PubMed   |  Link to Article

Figures

Place holder to copy figure label and caption
Graphic Jump Location

Figure 1. Histological examination of the varicella-zoster virus (VZV)–positive cerebral artery from neurologically asymptomatic diabetic subject 3. A, A hematoxylin-eosin–stained section of region 1 of VZV DNA–positive artery showed inflammation restricted to the arterial adventitia (arrow). B, Incubation of the adjacent section with rabbit anti-VZV gene 63 antibodies6 revealed VZV antigen in the adventitia of 5 consecutive arterial sections spanning 30 μm (arrows) that was not seen with control normal rabbit serum (C). D, A hematoxylin-eosin–stained section of region 2 approximately 150 μm downstream from region 1 of the VZV DNA–positive artery revealed minimal inflammation and no staining with rabbit anti-VZV IgG antibody (E) or control normal rabbit serum (F). G, A hematoxylin-eosin–stained section of region 3 approximately 150 μm downstream from region 2 again showed inflammation in the adventitia. Region 3 was positive for VZV antigen staining in all 10 sections spanning 60 μm (arrow) but not with control normal rabbit serum (I), indicating that VZV infection in the artery was not contiguous (original magnification ×200).

Place holder to copy figure label and caption
Graphic Jump Location

Figure 2. Detection of cells containing varicella-zoster virus and cells expressing CD45 antigen in noncontiguous regions of the arterial adventitia. Arterial regions 1 and 2 after incubation with a 1:400 dilution of mouse monoclonal anti-CD45 antibody (Dako). Region 1 contained varicella-zoster virus antigen (A, arrow) as well as cells expressing CD45 antigen (B, arrow). Region 2 did not contain varicella-zoster virus antigen (C) or cells expressing CD45 antigen (D). Region 3 was positive for varicella-zoster virus antigen and also contained CD45-positive cells (not shown) (original magnification ×600).

Tables

References

Kang JH, Ho JD, Chen YH, Lin HC. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study.  Stroke. 2009;40(11):3443-3448
PubMed   |  Link to Article
Lin HC, Chien CW, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study.  Neurology. 2010;74(10):792-797
PubMed   |  Link to Article
Heymann AD, Chodick G, Karpati T,  et al.  Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel.  Infection. 2008;36(3):226-230
PubMed   |  Link to Article
Cohrs RJ, Gilden DH. Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia.  J Virol. 2007;81(6):2950-2956
PubMed   |  Link to Article
Salazar R, Russman AN, Nagel MA,  et al.  Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement.  Arch Neurol. 2011;68:517-520
PubMed   |  Link to Article
Nagel MA, Traktinskiy I, Azarkh Y,  et al.  Varicella zoster virus vasculopathy: analysis of virus-infected arteries.  Neurology. 2011;77(4):364-370
PubMed   |  Link to Article

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
JAMAevidence.com